Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New tech aims to sharpen precision of liver cancer treatments

NCT ID NCT05582018

Summary

This study tested a new software tool called BioTraceIO 360, designed to help doctors plan, monitor, and assess procedures that use heat to destroy liver tumors. The goal was to see if the tool was safe and if it helped doctors position the treatment probes more accurately and confidently. The study was small and ended early.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Einstein Medical Center

    Philadelphia, Pennsylvania, 19141, United States

Conditions

Explore the condition pages connected to this study.